Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
04/2010
04/06/2010US7691968 Process for the synthesis of peptides amides by side-chain attachment to a solid phase
04/06/2010US7691884 Heterocyclic sulfonamide inhibitors of β amyloid production
04/06/2010CA2358505C Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
04/06/2010CA2252536C Ethylene derivatives and pesticides containing said derivatives
04/01/2010WO2010036404A2 Novel retinamide retinoic acid metabolism blocking agents
04/01/2010WO2010035915A1 Sulfur containing pyrazole-heterocycle derivatives as cannabinoid cb1 receptor antagonists
04/01/2010WO2010034118A1 Nitric oxide releasing amino acid ester compound, composition and method of use
04/01/2010WO2009116883A3 Catalytic asymetric hydrogenation
04/01/2010US20100081697 Crystalline freebase of 4'-{2-ethoxy-4-ethyl-5-[((S)-2-mercapto-4-methylpentanoylamino)methyl]imidazol-1-ylmethyl}-3'-fluorobiphenyl-2-carboxylic acid; stability; high melting point; nondeliquescent; hypotensive agents; heart failure; angiotensin II type 1 receptor antagonist; enkephalinase inhibitor
04/01/2010CA2775370A1 Nitric oxide releasing amino acid ester compound, composition and method of use
03/2010
03/31/2010EP2168951A1 Azolylmethylenehydrazine derivative and use thereof
03/31/2010EP2167475A2 Compound with anesthetics activity, methods for its production an pharmaceutical compositions comprising the same
03/31/2010EP2167474A1 Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases
03/31/2010EP2167464A1 Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor)
03/31/2010EP2167459A1 Novel triazine compounds for treatment of cancer
03/31/2010EP2167043A2 Nutraceutical co-crystal compositions
03/31/2010EP2166856A1 Chemical compounds
03/31/2010EP2076496B1 Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors
03/31/2010EP1904465B1 Method of synthesis of imidazole-amino acid derivatives and related compounds
03/31/2010EP1807393B1 Diarylsulfones as 5-ht2a antagonists
03/31/2010EP1620091B1 Inhibitors of glutaminyl cyclase
03/31/2010CN101687979A Resin composition
03/31/2010CN101687813A 1-(azolin-2-yl)amino-1,2-diphenylethane compounds for combating animal pests
03/31/2010CN101687812A 2 -imidazolines having a good affinity to the trace amine associated receptors (TAAR)
03/31/2010CN101687811A 4-imidazolines and their use as antidepressants
03/31/2010CN101687790A Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor)
03/30/2010US7687640 3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde; inhibits production of A beta 40 and A beta 42 from amyloid precursor protein ; Alzheimer's disease and Down syndrome
03/30/2010US7687525 e.g. N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; anticarcinogenic, antitumor agents; hematologic malignancy and a solid carcinoma; autoimmune disease, skin disorders;
03/30/2010US7687504 1-[3-[2-[2-cyano-(S)-pyrrolidin-1-yl]-2-oxo-ethylamino]-1-oxo-propyl]-4-[bis-(4-fluorophenyl)methyl]piperazine; inhibiting dipeptidyl peptidase IV or for treating Type II diabetes
03/30/2010CA2457444C 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
03/25/2010WO2010033043A1 Dendrimeric compounds comprising amino acids, hyperbranched core compound, process for preparation of dendrimeric compounds comprising amino acids and hyperbranched core compound, and use thereof
03/25/2010WO2010033014A2 Method for preparation of regenerative imidazolium reagents
03/25/2010WO2010031963A1 Low-toxicity biodegradable corrosion inhibitors
03/25/2010WO2010031848A1 Imidazole and triazole compounds, their use and agents containing the same
03/25/2010WO2010031847A1 Imidazole and triazole compounds, their use and agents containing the same
03/25/2010WO2010031843A1 Imidazole and triazole compounds, their use and agents containing the same
03/25/2010WO2010031842A1 Imidazole and triazole compounds, their use and agents containing the same
03/25/2010WO2010031721A1 Imidazole and triazole compounds, their use and agents containing the same
03/25/2010US20100076043 Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use
03/25/2010US20100075991 Post-translational regulation of catalytic activities of cytochrome P450 46A1 and uses thereof
03/25/2010US20100075968 Imidazolidine Carboxamide Derivatives as P2X7 Modulators
03/25/2010US20100075966 Substituted Dihydroimidazoles and their Use in the Treatment of Tumors
03/25/2010US20100075964 Imidazole based lxr modulators
03/25/2010DE102009022284A1 Entschwefelung von Kohlenwasserstoffen durch ionische Flüssigkeiten und Herstellungsverfahren Desulfurization of hydrocarbons by ionic liquids and methods of manufacture
03/24/2010EP2165709A2 Lysine based compounds
03/24/2010CN101679297A lxr and fxr modulators
03/24/2010CN101679296A Novel 4-phenyl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology
03/24/2010CN101679295A Novel 5-substituted hydantoins
03/24/2010CN101679294A Non-nucleoside reverse transcriptase inhibitors
03/24/2010CN101679293A Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases
03/24/2010CN101679292A Ionic liquid and method for producing the same
03/24/2010CN101679291A Imidazolidine carboxamide derivatives as P2X7 modulators
03/24/2010CN101679290A 3- to 7-membered 1,3-diaza-4-oxo-heterocyclic derivatives capable of releasing active aldehydes or ketones
03/24/2010CN101679289A ionic n-containing compounds
03/24/2010CN101677552A Aminoazoline and urea derivatives for combating animal pests
03/24/2010CN101676270A Novel imidazolidine derivative and use thereof
03/24/2010CN101676269A Functionalized united imidazole derivative and synthesizing method thereof
03/23/2010US7683089 4-[1-(2,3-dichloro-phenyl)-ethyl]-1,3-dihydro-imidazole-2-thione; cardiovascular and/or sedatory activity, pain; minimal side effects
03/23/2010US7683088 Compounds for the treatment of inflammatory disorders
03/18/2010WO2010030891A2 Aryl guanidine f1f0-atpase inhibitors and related methods
03/18/2010WO2010029576A2 Anti inflammatory compounds
03/18/2010WO2010029119A1 Novel imidazolidine compounds as androgen receptor modulators
03/18/2010WO2010029066A1 Imidazole and triazole compounds, use thereof and agents containing said compounds
03/18/2010WO2010029065A1 Imidazole and triazole compounds, use thereof and agents containing said compounds
03/18/2010WO2010029029A1 Imidazole- und triazole compounds, their use, and agents containing the same
03/18/2010WO2010029028A1 Imidazole compounds, use thereof, and substances containing the same
03/18/2010WO2010028986A1 Imidazole and triazole compounds, the use thereof and preparations containing these compounds
03/18/2010WO2010008522A3 Nucleophilic fluorination of aromatic compounds
03/18/2010WO2009137651A8 Fungicidal substituted azoles
03/18/2010US20100069630 Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same
03/18/2010US20100069454 Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
03/18/2010US20100069453 Certain Chemical Entities, Compositions, and Methods
03/18/2010US20100069452 Mineralocorticoid receptor modulators
03/18/2010US20100069446 L-threonine derivatives of high therapeutic index
03/18/2010US20100069405 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
03/18/2010US20100069367 LXR and FXR Modulators
03/18/2010US20100068786 Methods and compositions for reversing p-glycoprotein medicated drug resistance
03/17/2010EP2163545A1 Ionic liquid and method for producing the same
03/17/2010EP2162441A2 1,(3,)5-substituted imidazoles, their use in the treatment of hypertension and methods for their preparation
03/17/2010CN101671370A Ionic liquid type iron (III) complex and application thereof
03/17/2010CN101671336A Aromatic heterocyclic pyridine derivatives and analogs and preparation method and application thereof
03/17/2010CN101671307A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors
03/17/2010CN101671306A Preparation method of L-carnosine
03/17/2010CN101671305A Method for resolution of levorotatory enantiomer and dexiotropic enantiomer of medetomidine
03/17/2010CN101671304A Ionic liquid containing cinnamyl functional groups and preparation method thereof
03/16/2010US7678923 Method for synthesizing 5-chloro-1-aryl-4-(4,5-dicyano-1h-imidazol-2-yl)-3-alkyl-1h-pyrazole derivatives
03/16/2010US7678918 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents
03/16/2010US7678812 Aminotetralin-derived urea modulators of vanilloid VR1 receptor
03/16/2010CA2396965C Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
03/16/2010CA2336846C Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric g protein
03/11/2010WO2010028189A2 Compounds, compositions and methods of using same for modulating uric acid levels
03/11/2010WO2010028032A2 Process for synthesis of imidazolium and benzimidazolium surfactants and their use in clays and nanocomposites
03/11/2010WO2010027077A1 2-benzyl-4-(3,4-dichlorophenyl)-5-methylimidazole compound
03/11/2010WO2010025558A1 Triazolium and imidazolium salts and uses thereof as antimalarials
03/11/2010WO2010011821A3 Dual-acting antihypertensive agents
03/11/2010WO2009080818A3 Guanidine based compounds
03/11/2010US20100063120 Imidazolidine Derivatives, Uses Therefor, Preparation Thereof and Compositions Comprising Such
03/11/2010US20100063119 Substituted carbinol compound
03/11/2010US20100063118 Hydantoins Having RNase Modulatory Activity
03/11/2010US20100063050 Novel heteropyrrole analogs acting on cannabinoid receptors
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 345